- Home
- TMC vs CNTA Comparison
TMC vs CNTA Comparison
Compare TMC & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMC
- CNTA
- Stock Information
- Founded
- TMC 2011
- CNTA 2020
- Country
- TMC Canada
- CNTA United Kingdom
- Employees
- TMC N/A
- CNTA N/A
- Industry
- TMC Metal Mining
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- TMC Basic Materials
- CNTA Health Care
- Exchange
- TMC Nasdaq
- CNTA Nasdaq
- Market Cap
- TMC 2.9B
- CNTA 2.3B
- IPO Year
- TMC N/A
- CNTA 2021
- Fundamental
- Price
- TMC $5.26
- CNTA $27.70
- Analyst Decision
- TMC Strong Buy
- CNTA Strong Buy
- Analyst Count
- TMC 4
- CNTA 9
- Target Price
- TMC $6.94
- CNTA $34.13
- AVG Volume (30 Days)
- TMC 7.3M
- CNTA 2.2M
- Earning Date
- TMC 11-13-2025
- CNTA 11-05-2025
- Dividend Yield
- TMC N/A
- CNTA N/A
- EPS Growth
- TMC N/A
- CNTA N/A
- EPS
- TMC N/A
- CNTA N/A
- Revenue
- TMC N/A
- CNTA $15,000,000.00
- Revenue This Year
- TMC N/A
- CNTA N/A
- Revenue Next Year
- TMC N/A
- CNTA N/A
- P/E Ratio
- TMC N/A
- CNTA N/A
- Revenue Growth
- TMC N/A
- CNTA 118.88
- 52 Week Low
- TMC $0.72
- CNTA $9.60
- 52 Week High
- TMC $11.35
- CNTA $29.33
- Technical
- Relative Strength Index (RSI)
- TMC 37.26
- CNTA 64.70
- Support Level
- TMC $4.75
- CNTA $27.15
- Resistance Level
- TMC $6.14
- CNTA $29.29
- Average True Range (ATR)
- TMC 0.46
- CNTA 2.21
- MACD
- TMC -0.07
- CNTA 0.40
- Stochastic Oscillator
- TMC 21.62
- CNTA 85.91
About TMC TMC the metals company Inc.
TMC The Metals Co Inc is a deep-sea minerals exploration company focused on the collection, processing, and refining of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone (CCZ). Polymetallic nodules are discrete rocks that sit unattached to the seafloor, occur in notable quantities in the CCZ, and have high concentrations of nickel, copper, cobalt, and manganese in a single rock. The company believes these four metals contained in the polymetallic nodules are critical for energy infrastructure and industrial manufacturing. The Company's business consists of only one operating segment, namely exploration of seafloor polymetallic nodules, which includes the development of a metallurgical process to treat such seafloor polymetallic nodules.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.